News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Fire Fox post# 278786

Wednesday, 11/16/2016 12:10:46 PM

Wednesday, November 16, 2016 12:10:46 PM

Post# of 347009
Firefox, friend just bought 25,000 PPHM shares after reading this weeks PR about Peregrine and they also wondered why it was not clearly written like yours

Fourier Transforms are also very boring to those who don't understand but once some understand the formula works just like PS Targeting, as confirmed by Dr Wolchok ...

Has there ever been a lawsuit vs a PR marketing firm ? I just started wondering if the reason why they went with a PR firm ...to be shielded from a lawsuit that says the company was not being upfront with shareholders....in telling them in a way that retail understands them 100%

Some or many should start sending Peregrine emails and better yet, certified letters to the BODs and Mark Z about these concerns, because we would not want a lawsuit out there because of not being clear 100% in PRs

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y